NEK2 and diffuse large B-cell lymphoma: On the basis of bioinformatic analyses, we demonstrated that NEK2 was upregulated in DLBCL compared to normal lymphoid tissue, and overexpression of NEK2 predicted a worse prognosis of DLBCL patients.